Dr. Elisabeth J. Cohen is enhancing the department’s longstanding commitment to research.

Together, psilocybin and psychotherapy reduced alcohol consumption by 83 percent among heavy drinkers.

Dr. Elaine Shum is leading this trial, which aims to fill an unmet need for targeted therapies.

Joining the Experimental Therapeutics Clinical Trials Network advances cancer clinical trial capabilities.

Adjuvant immunotherapy could help people avoid treatment for metastatic melanoma.

Dr. Catherine S. Diefenbach serves as the principal investigator for numerous lymphoma clinical trials.

Dr. Jeffrey Weber says a person’s microbiome may impact the effectiveness of checkpoint inhibitor therapy.

Stand Up To Cancer grant will provide technology-enabled monitoring of immunotherapy side effects.

Melissa Honkanen was the world’s first participant to be vaccinated in the Pfizer–BioNTech vaccine study.

Immunotherapy and measuring circulating tumor DNA are among the advances for treating head and neck cancer.